Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer.
Krzyzanowska A, Higgins DF, Barron S, Loughman T, O'Neill A, Sheehan KM, Wang CA, Fender B, McGuire L, Fay J, O'Grady A, O'Leary D, Watson RW, Bjartell A, Gallagher WM.
Krzyzanowska A, et al. Among authors: wang ca.
BJUI Compass. 2024 Dec 13;6(1):e474. doi: 10.1002/bco2.474. eCollection 2025 Jan.
BJUI Compass. 2024.
PMID: 39877562
Free PMC article.